About Us

What We Do

MedTech Atlas helps medical device and pharmaceutical teams understand global market-access requirements before they commit budget, timelines, and local partners.

We organize country-level regulatory information into practical guides covering registration pathways, competent authorities, local holder or agent expectations, dossier requirements, timing, cost drivers, and post-market obligations.

Beyond the reference library, we support medical device teams with regulatory consulting and localization implementation planning: pathway assessment, certificate leverage, local holder model, dossier conversion, labeling, and post-market responsibility planning.

Who We Serve

Our work is built for manufacturers, exporters, regulatory affairs teams, quality and compliance leaders, business development teams, distributors, local partners, consultants, and investors who need to compare markets quickly and identify the next questions to verify before filing.

Typical users come to us when they are asking:

• Which country should we enter first?
• Does an existing FDA, CE, NMPA, or other approval help in the target market?
• Do we need a local representative, importer, license holder, or registration certificate holder?
• What documents, translations, testing, and post-market systems should be planned before submission?
• Which market-entry risks should be discussed before signing with a local partner?

How The Service Works

Public pages provide high-level market and pathway context. During the limited-time free access period, registered and signed-in users can read complete country reports for medical devices and pharmaceuticals.

The country reports are designed as decision-support material: they help teams scope a market-entry plan, prepare internal discussions, and decide where professional filing support or local verification is needed.

Our Approach

We focus on clarity, comparability, and practical execution. Regulation is not only a list of laws; it is a sequence of decisions about product classification, evidence strategy, local responsibility, timing, cost, and post-market control.

MedTech Atlas turns that sequence into structured research that is easier to compare across countries.

The team background includes nearly 20 years of compliance work, global certification experience, and multi-country localization planning. See Trust for the delivery method and Consulting Services for project follow-up.

Important Note

MedTech Atlas provides regulatory intelligence and market-access research. It is not a law firm, notified body, regulator, or filing agent. Requirements can change, and final submission decisions should always be verified against the latest regulator guidance and qualified local advice.

Contact

For product-specific discussion, leave your company, product, current approvals, and target countries through the project consultation form.